欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
CZ/H/1434/001
药品名称
Goserelin Alvogen
活性成分
Goserelin acetate 3.6 mg
剂型
IMPLANT IN PRE-FILLED SYRINGE
上市许可持有人
Alvogen IPCo S.A.R.L.
参考成员国 - 产品名称
Czechia (CZ)
互认成员国 - 产品名称
Portugal (PT)
Iceland (IS)
Poland (PL)
Latvia (LV)
Reseligo 3,6 mg implants pilnšļircē
Lithuania (LT)
Reseligo 3,6 mg implantas užpildytame švirkšte
Estonia (EE)
RESELIGO
Hungary (HU)
Reseligo 3,6 mg implantátum előretöltött fecskendőben
Bulgaria (BG)
Goserelin Alvogen
Romania (RO)
Reseligo 3,6 mg implant, in seringa preumpluta
Slovakia (SK)
Slovenia (SI)
Croatia (HR)
Reseligo 3,6 mg implantat u napunjenoj štrcaljki
许可日期
2015/10/08
最近更新日期
2025/01/14
药物ATC编码
L02AE03 goserelin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
common_impack_syringe_clean
Date of last change:2024/09/06
Final Product Information
|
common_outer_carton_clean
Date of last change:2024/09/06
Final Product Information
|
common_outer_instruction_card_clean
Date of last change:2024/09/06
Final Product Information
|
common_pl_clean
Date of last change:2024/09/06
Final Product Information
|
common_pouch
Date of last change:2024/09/06
Final Product Information
|
common_spc_clean
Date of last change:2024/09/06
PubAR
|
PT_1276_Reseligo_PAR_final
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase